LD
Livija Deban
Prokarium
Chief Scientific Officer
Description
Livija leads the strategic and operational development of Prokarium's immuno-oncology portfolio, focused on bioengineering Living Cures for solid tumors. Before joining Prokarium in 2018, she led the lead selection and immuno-oncology R&D at Oxford BioTherapeutics, focusing on target discovery and the development of immunomodulatory antibodies for cancer treatment. Livija conducted her academic research at Cancer Research UK and holds a PhD in Basic and Applied Immunology.
Loading